Empagliflozin with methotrexate for rheumatoid arthritis
Treatments studied
Part of Bones, joints & muscles, Immune system & allergy, Skin clinical trials.
This trial tests whether adding empagliflozin to methotrexate helps reduce rheumatoid arthritis activity compared to methotrexate alone. It may protect joints from further damage.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 60 years old.
- You must have active rheumatoid arthritis (not in remission).
- You must be taking methotrexate.
- You must not have serious liver, kidney, or blood problems.
- You must not be pregnant or breastfeeding.
- You must not be taking other biologic arthritis drugs or antioxidants during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether two diabetes medications, dapagliflozin and empagliflozin, can help reduce rheumatoid arthritis symptoms when added to your current methotrexate treatment. It may offer a new option for people whose arthritis is still active despite methotrexate.
This trial tests whether adding silymarin (a natural supplement from milk thistle) to standard methotrexate treatment can improve symptoms of rheumatoid arthritis. It may help reduce joint pain and swelling for people who are not yet in remission.
This study tests a methotrexate injection (given under the skin) for people with moderate to severe rheumatoid arthritis who haven't taken methotrexate before. Researchers want to see how the medicine builds up in your body and if it helps control your symptoms.
This study compares two oral medications, tofacitinib and upadacitinib, when added to methotrexate for people with rheumatoid arthritis. The goal is to see which one works better and is safer for controlling symptoms.
This study looks at how well methotrexate injections work in people with rheumatoid arthritis. It is designed for patients who are starting or changing to this type of methotrexate treatment.
This trial tests if empagliflozin, a medicine used for diabetes, can help protect kidney function in people with active lupus nephritis. You may be eligible if you have a lupus kidney flare with significant protein in your urine.
Hear when a new Rheumatoid Arthritis (RA) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.